Biocryst Pharmaceuticals Inc (BCRX)
Cost of Revenue
$719.42M
TTM · Period ending: · USD
BCRX Cost of Revenue
Latest reported$719.42Mperiod ending
Latest reported$719.42Mperiod ending
BCRX Cost of Revenue ($5.00M → $719.42M)
Annual cost of revenue
High-resolution chart · PNG
BCRX cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 19,075,000 | |
| 12,485,000 | |
| 4,661,000 | |
| 6,594,000 | |
| 7,264,000 | |
| 1,676,000 | |
| 4,101,000 | |
| 471,000 | |
| 1,702,000 | |
| 2,699,000 | |
| 1,896,000 | |
| 122,000 | |
| 98,000 | |
| 132,000 | |
| 0 | |
| 86,000 | |
| 4,544,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -500,000 | |
| -500,000 | |
| -600,000 | |
| 7,100,000 | |
| 6,500,000 | |
| 5,000,000 |